Pfizer (PFE)

Novo Nordisk's drug trial failure is the latest in a series of 2025 woes for the company.

Looking for the most active stocks in the S&P500 index on Friday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.

From high-yield pharma plays to growth-oriented compounders, these eight stocks offer something for every dividend investor.

While Pfizer has lagged behind the broader Dow Jones Industrial Average, Wall Street remains optimistic about the stock.

Roivant (ROIV) Q2 2026 Earnings Call Transcript

These top dividend stocks could intrigue a wide range of investors.

JPMorgan said the implied net impact aligns with recent commentary from Novo Nordisk, Teva and AbbVie during earnings season.

Valneva's Phase 2 data show strong, lasting immunity for its Pfizer-partnered Lyme vaccine as the company consolidates operations in France.

Merck has outperformed the healthcare sector over the past three months. Moreover, Wall Street analysts are moderately optimistic about its prospects.

The weight loss drug market may approach almost $100 billion by the end of the decade.

The financial markets are currently navigating a turbulent sea of uncertainty, grappling with the profound implications of significantly delayed economic reports. As of November 25, 2025, the aftershocks of a recent 43-day U.S. government shutdown, which concluded on November 12th, have created an unprecedented "information vacuum." This scarcity of

This big pharma stock should be even more appealing to investors amid market turbulence.

Although the U.S. stock market is trading close to an all-time high, its dividend yield is approaching a 20-year low, and that's creating a challenge for income-oriented investors.

Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.

Copenhagen, Denmark – November 24, 2025 – Novo Nordisk's (CPH: NOVO B) stock experienced a significant and immediate downturn today, plummeting by over 10% in early trading, following the announcement of disappointing results from its highly anticipated late-stage clinical trials for an Alzheimer's disease drug. The trials, which tested an oral formulation

The Schwab U.S. Dividend Equity ETF and Alerian MLP ETF are two nice high-yield ETF options.

For those with decades left in their investing journey, these top healthcare stocks could be worthy portfolio contenders.

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. 

Pfizer rises after a study found that the company's new mRNA flu vaccine outperforms traditional shots against predominant strains.

Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Friday and discover the stocks that are dominating the trading activity and setting the pace for the market.

Texas sues Sanofi and Bristol-Myers Squibb over alleged Plavix failures, as Paxton also finalizes a $41.5 million settlement with Pfizer and Tris over quality issues in children's medication.

The drugmaker may not continue to lag the market for much longer.

The investment bank's analysts simply recognize how much has changed in just the past few years, and what that means for the near future.

Artificial intelligence is rapidly transforming America's healthcare system, offering immediate and profound benefits across the entire spectrum of care, from individual patients to providers and public health initiatives. For patients, AI is leading to earlier, more accurate diagnoses and highly personalized treatment plans. Machine learning algorithms can analyze vast amounts of medical data, including imaging [...]

Exact Sciences stock rallies as Abbott announces a $21 billion deal to acquire to the molecular diagnostics firm. Here’s why EXAS shares are unlikely to push any higher in 2026.